+1 855 639 5863

info@rubixls.com

[Infographic] Can Digitalization Save Life on Earth?

[Infographic] Can Digitalization Save Life on Earth?

As the world contends with new challenges with global warming, one of the threats humankind will be challenged with mitigating are ancient diseases. While 2 new diseases are identified every week, the scale of what we thought we were able to cure may not be as...
CRISPR –  A genetic revolution or an enormous threat?

CRISPR – A genetic revolution or an enormous threat?

It outraged scientists across the globe. Media outlets were stunned. In November 2018, a scientist in China, He Jiankui, reported that he had created the world’s first human babies with CRISPR-edited genes: a pair of twin girls resistant to HIV. The director of the...

Diversity Alliance For Science Conference

Recently, the founder and CEO, Reginald Swift, had the opportunity to connect with the wider biotech community. As the nature of society is changing toward inclusion for diversity, the life science sector is creating initiatives to do the same for partnering with...
Unpacking the reality of Bioterrorism in 2018

Unpacking the reality of Bioterrorism in 2018

Anthrax. Ebola. Smallpox. These are just a few of the biological agents that could be weaponized for a bioterrorism attack and unlike a bombing or shooting, these microbial agents can incubate for days or weeks going unnoticed until unrelenting illnesses or deaths...
Exploring the Challenges of Clinical Trial Failures

Exploring the Challenges of Clinical Trial Failures

Creating a new drug is undoubtedly harrowing. The success rate of clinical trials is dependent on many factors such as patient enrollment, efficacy, bureaucracy, and awareness of the general public. These concerns are influential factors that ultimately affect which...